Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies

Identifieur interne : 00CD82 ( Main/Exploration ); précédent : 00CD81; suivant : 00CD83

Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies

Auteurs : Martine Chatelut [France] ; Klaus Harzer [Allemagne] ; Helen Christomanou [Grèce] ; Jean Feunteun [France] ; Marie-Thérèse Pieraggi [France] ; Barbara C. Paton [Australie] ; Yasuo Kishimoto [États-Unis] ; John S. O'Brien [États-Unis] ; Jean-Pierre Basile [France] ; Jean-Claude Thiers [France] ; Robert Salvayre [France] ; Thierry Levade [France]

Source :

RBID : ISTEX:DCFFFFDE3F417DC08D4E382405F19004B4C73D91

Descripteurs français

English descriptors

Abstract

Abstract: Skin fibroblasts from patients with Farber disease (acid ceramidase deficiency) and from two siblings of the only known family affected with prosaposin deficiency were transformed by transfection with a plasmid carrying the SV40 large T antigen. The prosaposin-deficient transformed cell lines conserved their original metabolic defects, and in particular they were free of detectable immunoreactivity when using anti-saposin B and anti-saposin C antisera. Ultrastructurally, the cells contained heterogeneous lysosomal storage products. As found for their parental cell lines, the SV40-transformed fibroblasts exhibited deficient in vitro activities of lysosomal ceramidase and β-galactosylceramidase, but a normal activity of acid sphingomyelinase. As observed for SV40-transformed fibroblasts from Farber disease, degradation of radioactive glucosylceramide or low density lipoprotein-associated radiolabelled sphingomyelin by the prosaposin-deficient cells in situ showed a clear impairment in the turnover of lysosomal ceramide. Ceramide storage in prosaposin-deficient cells was also demonstrated by ceramide mass determination. In contrast to acid ceramidase deficient cells, both the accumulation of ceramide and the reduced in vitro activity of acid ceramidase in cells from prosaposin deficiency could be corrected by addition of purified saposin D. The data confirm that prosaposin is required for lysosomal ceramide degradation, but not for sphingomyelin turnover. The SV40-transformed fibroblasts will be useful for pathophysiological studies on human prosaposin deficiency.

Url:
DOI: 10.1016/S0009-8981(97)06527-3


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies</title>
<author>
<name sortKey="Chatelut, Martine" sort="Chatelut, Martine" uniqKey="Chatelut M" first="Martine" last="Chatelut">Martine Chatelut</name>
</author>
<author>
<name sortKey="Harzer, Klaus" sort="Harzer, Klaus" uniqKey="Harzer K" first="Klaus" last="Harzer">Klaus Harzer</name>
</author>
<author>
<name sortKey="Christomanou, Helen" sort="Christomanou, Helen" uniqKey="Christomanou H" first="Helen" last="Christomanou">Helen Christomanou</name>
</author>
<author>
<name sortKey="Feunteun, Jean" sort="Feunteun, Jean" uniqKey="Feunteun J" first="Jean" last="Feunteun">Jean Feunteun</name>
</author>
<author>
<name sortKey="Pieraggi, Marie Therese" sort="Pieraggi, Marie Therese" uniqKey="Pieraggi M" first="Marie-Thérèse" last="Pieraggi">Marie-Thérèse Pieraggi</name>
</author>
<author>
<name sortKey="Paton, Barbara C" sort="Paton, Barbara C" uniqKey="Paton B" first="Barbara C." last="Paton">Barbara C. Paton</name>
</author>
<author>
<name sortKey="Kishimoto, Yasuo" sort="Kishimoto, Yasuo" uniqKey="Kishimoto Y" first="Yasuo" last="Kishimoto">Yasuo Kishimoto</name>
</author>
<author>
<name sortKey="O Brien, John S" sort="O Brien, John S" uniqKey="O Brien J" first="John S." last="O'Brien">John S. O'Brien</name>
</author>
<author>
<name sortKey="Basile, Jean Pierre" sort="Basile, Jean Pierre" uniqKey="Basile J" first="Jean-Pierre" last="Basile">Jean-Pierre Basile</name>
</author>
<author>
<name sortKey="Thiers, Jean Claude" sort="Thiers, Jean Claude" uniqKey="Thiers J" first="Jean-Claude" last="Thiers">Jean-Claude Thiers</name>
</author>
<author>
<name sortKey="Salvayre, Robert" sort="Salvayre, Robert" uniqKey="Salvayre R" first="Robert" last="Salvayre">Robert Salvayre</name>
</author>
<author>
<name sortKey="Levade, Thierry" sort="Levade, Thierry" uniqKey="Levade T" first="Thierry" last="Levade">Thierry Levade</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:DCFFFFDE3F417DC08D4E382405F19004B4C73D91</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1016/S0009-8981(97)06527-3</idno>
<idno type="url">https://api.istex.fr/document/DCFFFFDE3F417DC08D4E382405F19004B4C73D91/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002929</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002929</idno>
<idno type="wicri:Area/Istex/Curation">002929</idno>
<idno type="wicri:Area/Istex/Checkpoint">002423</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002423</idno>
<idno type="wicri:doubleKey">0009-8981:1997:Chatelut M:model:sv:transformed</idno>
<idno type="wicri:Area/Main/Merge">00DE85</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:97-0493913</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">006911</idno>
<idno type="wicri:Area/PascalFrancis/Curation">006758</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">006684</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">006684</idno>
<idno type="wicri:doubleKey">0009-8981:1997:Chatelut M:model:sv:transformed</idno>
<idno type="wicri:Area/Main/Merge">00E120</idno>
<idno type="wicri:Area/Main/Curation">00CD82</idno>
<idno type="wicri:Area/Main/Exploration">00CD82</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies</title>
<author>
<name sortKey="Chatelut, Martine" sort="Chatelut, Martine" uniqKey="Chatelut M" first="Martine" last="Chatelut">Martine Chatelut</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie, “Maladies Métaboliques”, INSERM U. 466, Institut Louis Bugnard, C.H.U. Rangueil, F-31403 Toulouse</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Harzer, Klaus" sort="Harzer, Klaus" uniqKey="Harzer K" first="Klaus" last="Harzer">Klaus Harzer</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Neurochemical Laboratory, Institut für Hirnforschung, University of Tübingen, Tübingen</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Tübingen</region>
<settlement type="city">Tübingen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Christomanou, Helen" sort="Christomanou, Helen" uniqKey="Christomanou H" first="Helen" last="Christomanou">Helen Christomanou</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Laboratory of Neurochemistry and Molecular Biology, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Feunteun, Jean" sort="Feunteun, Jean" uniqKey="Feunteun J" first="Jean" last="Feunteun">Jean Feunteun</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Génétique Oncologique, U.R.A. 1967 CNRS, Institut Gustave Roussy, Villejuif</wicri:regionArea>
<wicri:noRegion>Villejuif</wicri:noRegion>
<wicri:noRegion>Villejuif</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Pieraggi, Marie Therese" sort="Pieraggi, Marie Therese" uniqKey="Pieraggi M" first="Marie-Thérèse" last="Pieraggi">Marie-Thérèse Pieraggi</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie, “Maladies Métaboliques”, INSERM U. 466, Institut Louis Bugnard, C.H.U. Rangueil, F-31403 Toulouse</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Paton, Barbara C" sort="Paton, Barbara C" uniqKey="Paton B" first="Barbara C." last="Paton">Barbara C. Paton</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Chemical Pathology, Women's and Children's Hospital, North Adelaide</wicri:regionArea>
<wicri:noRegion>North Adelaide</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kishimoto, Yasuo" sort="Kishimoto, Yasuo" uniqKey="Kishimoto Y" first="Yasuo" last="Kishimoto">Yasuo Kishimoto</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurosciences, University of California-San Diego, Center for Molecular Genetics, La Jolla, CA</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="O Brien, John S" sort="O Brien, John S" uniqKey="O Brien J" first="John S." last="O'Brien">John S. O'Brien</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurosciences, University of California-San Diego, Center for Molecular Genetics, La Jolla, CA</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Basile, Jean Pierre" sort="Basile, Jean Pierre" uniqKey="Basile J" first="Jean-Pierre" last="Basile">Jean-Pierre Basile</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie, “Maladies Métaboliques”, INSERM U. 466, Institut Louis Bugnard, C.H.U. Rangueil, F-31403 Toulouse</wicri:regionArea>
<wicri:noRegion>31403 Toulouse</wicri:noRegion>
<wicri:noRegion>F-31403 Toulouse</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Thiers, Jean Claude" sort="Thiers, Jean Claude" uniqKey="Thiers J" first="Jean-Claude" last="Thiers">Jean-Claude Thiers</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie, “Maladies Métaboliques”, INSERM U. 466, Institut Louis Bugnard, C.H.U. Rangueil, F-31403 Toulouse</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Salvayre, Robert" sort="Salvayre, Robert" uniqKey="Salvayre R" first="Robert" last="Salvayre">Robert Salvayre</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie, “Maladies Métaboliques”, INSERM U. 466, Institut Louis Bugnard, C.H.U. Rangueil, F-31403 Toulouse</wicri:regionArea>
<wicri:noRegion>31403 Toulouse</wicri:noRegion>
<wicri:noRegion>F-31403 Toulouse</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Levade, Thierry" sort="Levade, Thierry" uniqKey="Levade T" first="Thierry" last="Levade">Thierry Levade</name>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie, “Maladies Métaboliques”, INSERM U. 466, Institut Louis Bugnard, C.H.U. Rangueil, F-31403 Toulouse</wicri:regionArea>
<wicri:noRegion>31403 Toulouse</wicri:noRegion>
<wicri:noRegion>F-31403 Toulouse</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">France</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Clinica Chimica Acta</title>
<title level="j" type="abbrev">CCA</title>
<idno type="ISSN">0009-8981</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1997">1997</date>
<biblScope unit="volume">262</biblScope>
<biblScope unit="issue">1–2</biblScope>
<biblScope unit="page" from="61">61</biblScope>
<biblScope unit="page" to="76">76</biblScope>
</imprint>
<idno type="ISSN">0009-8981</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0009-8981</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acid ceramidase</term>
<term>Acid ceramidase activity</term>
<term>Acid sphingomyelinase</term>
<term>Acta</term>
<term>Activator</term>
<term>Assay</term>
<term>Biochem</term>
<term>Biol</term>
<term>Biol chem</term>
<term>Biological model</term>
<term>Cell immortalization</term>
<term>Cell lines</term>
<term>Ceramidase</term>
<term>Ceramide</term>
<term>Chatelut</term>
<term>Chem</term>
<term>Chimica</term>
<term>Clinica</term>
<term>Clinica chimica acta</term>
<term>Control cells</term>
<term>Degradation</term>
<term>Established cell line</term>
<term>Farber</term>
<term>Farber disease</term>
<term>Fetal</term>
<term>Fetal sibling</term>
<term>Fibroblast</term>
<term>Gaucher</term>
<term>Gaucher spleen</term>
<term>Harzer</term>
<term>Human</term>
<term>Human prosaposin deficiency</term>
<term>Initiation codon</term>
<term>Kishimoto</term>
<term>Lipid</term>
<term>Lipids</term>
<term>Liquid scintillation</term>
<term>Loading test</term>
<term>Lysosomal</term>
<term>Lysosomal degradation</term>
<term>Lysosomal storage disease</term>
<term>Prosaposin</term>
<term>Prosaposin deficiency</term>
<term>Prosaposin gene</term>
<term>Pure saposin</term>
<term>SV40 virus</term>
<term>Sandhoff</term>
<term>Saposin</term>
<term>Saposins</term>
<term>Sibling</term>
<term>Skin fibroblasts</term>
<term>Sphingolipid</term>
<term>Sphingolipid activator protein</term>
<term>Sphingomyelin</term>
<term>Sphingomyelinase</term>
<term>Untransformed</term>
<term>Untransformed cells</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Fibroblaste</term>
<term>Homme</term>
<term>Immortalisation cellulaire</term>
<term>Lignée cellulaire établie</term>
<term>Lipide</term>
<term>Lysosome pathologie</term>
<term>Modèle biologique</term>
<term>Saposine</term>
<term>Sphingolipidose héréditaire Farber</term>
<term>Virus SV40</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Acid ceramidase</term>
<term>Acid ceramidase activity</term>
<term>Acid sphingomyelinase</term>
<term>Acta</term>
<term>Activator</term>
<term>Assay</term>
<term>Biochem</term>
<term>Biol</term>
<term>Biol chem</term>
<term>Cell lines</term>
<term>Ceramidase</term>
<term>Ceramide</term>
<term>Chatelut</term>
<term>Chem</term>
<term>Chimica</term>
<term>Clinica</term>
<term>Clinica chimica acta</term>
<term>Control cells</term>
<term>Degradation</term>
<term>Farber</term>
<term>Farber disease</term>
<term>Fetal</term>
<term>Fetal sibling</term>
<term>Fibroblast</term>
<term>Gaucher</term>
<term>Gaucher spleen</term>
<term>Harzer</term>
<term>Human prosaposin deficiency</term>
<term>Initiation codon</term>
<term>Kishimoto</term>
<term>Lipid</term>
<term>Liquid scintillation</term>
<term>Loading test</term>
<term>Lysosomal</term>
<term>Lysosomal degradation</term>
<term>Prosaposin</term>
<term>Prosaposin deficiency</term>
<term>Prosaposin gene</term>
<term>Pure saposin</term>
<term>Sandhoff</term>
<term>Saposin</term>
<term>Saposins</term>
<term>Sibling</term>
<term>Skin fibroblasts</term>
<term>Sphingolipid</term>
<term>Sphingolipid activator protein</term>
<term>Sphingomyelin</term>
<term>Sphingomyelinase</term>
<term>Untransformed</term>
<term>Untransformed cells</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Skin fibroblasts from patients with Farber disease (acid ceramidase deficiency) and from two siblings of the only known family affected with prosaposin deficiency were transformed by transfection with a plasmid carrying the SV40 large T antigen. The prosaposin-deficient transformed cell lines conserved their original metabolic defects, and in particular they were free of detectable immunoreactivity when using anti-saposin B and anti-saposin C antisera. Ultrastructurally, the cells contained heterogeneous lysosomal storage products. As found for their parental cell lines, the SV40-transformed fibroblasts exhibited deficient in vitro activities of lysosomal ceramidase and β-galactosylceramidase, but a normal activity of acid sphingomyelinase. As observed for SV40-transformed fibroblasts from Farber disease, degradation of radioactive glucosylceramide or low density lipoprotein-associated radiolabelled sphingomyelin by the prosaposin-deficient cells in situ showed a clear impairment in the turnover of lysosomal ceramide. Ceramide storage in prosaposin-deficient cells was also demonstrated by ceramide mass determination. In contrast to acid ceramidase deficient cells, both the accumulation of ceramide and the reduced in vitro activity of acid ceramidase in cells from prosaposin deficiency could be corrected by addition of purified saposin D. The data confirm that prosaposin is required for lysosomal ceramide degradation, but not for sphingomyelin turnover. The SV40-transformed fibroblasts will be useful for pathophysiological studies on human prosaposin deficiency.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Australie</li>
<li>France</li>
<li>Grèce</li>
<li>États-Unis</li>
</country>
<region>
<li>Attique (région)</li>
<li>Bade-Wurtemberg</li>
<li>Californie</li>
<li>District de Tübingen</li>
<li>Midi-Pyrénées</li>
<li>Occitanie (région administrative)</li>
</region>
<settlement>
<li>Athènes</li>
<li>Toulouse</li>
<li>Tübingen</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Occitanie (région administrative)">
<name sortKey="Chatelut, Martine" sort="Chatelut, Martine" uniqKey="Chatelut M" first="Martine" last="Chatelut">Martine Chatelut</name>
</region>
<name sortKey="Basile, Jean Pierre" sort="Basile, Jean Pierre" uniqKey="Basile J" first="Jean-Pierre" last="Basile">Jean-Pierre Basile</name>
<name sortKey="Feunteun, Jean" sort="Feunteun, Jean" uniqKey="Feunteun J" first="Jean" last="Feunteun">Jean Feunteun</name>
<name sortKey="Levade, Thierry" sort="Levade, Thierry" uniqKey="Levade T" first="Thierry" last="Levade">Thierry Levade</name>
<name sortKey="Levade, Thierry" sort="Levade, Thierry" uniqKey="Levade T" first="Thierry" last="Levade">Thierry Levade</name>
<name sortKey="Pieraggi, Marie Therese" sort="Pieraggi, Marie Therese" uniqKey="Pieraggi M" first="Marie-Thérèse" last="Pieraggi">Marie-Thérèse Pieraggi</name>
<name sortKey="Salvayre, Robert" sort="Salvayre, Robert" uniqKey="Salvayre R" first="Robert" last="Salvayre">Robert Salvayre</name>
<name sortKey="Thiers, Jean Claude" sort="Thiers, Jean Claude" uniqKey="Thiers J" first="Jean-Claude" last="Thiers">Jean-Claude Thiers</name>
</country>
<country name="Allemagne">
<region name="Bade-Wurtemberg">
<name sortKey="Harzer, Klaus" sort="Harzer, Klaus" uniqKey="Harzer K" first="Klaus" last="Harzer">Klaus Harzer</name>
</region>
</country>
<country name="Grèce">
<region name="Attique (région)">
<name sortKey="Christomanou, Helen" sort="Christomanou, Helen" uniqKey="Christomanou H" first="Helen" last="Christomanou">Helen Christomanou</name>
</region>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Paton, Barbara C" sort="Paton, Barbara C" uniqKey="Paton B" first="Barbara C." last="Paton">Barbara C. Paton</name>
</noRegion>
</country>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Kishimoto, Yasuo" sort="Kishimoto, Yasuo" uniqKey="Kishimoto Y" first="Yasuo" last="Kishimoto">Yasuo Kishimoto</name>
</region>
<name sortKey="O Brien, John S" sort="O Brien, John S" uniqKey="O Brien J" first="John S." last="O'Brien">John S. O'Brien</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00CD82 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00CD82 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:DCFFFFDE3F417DC08D4E382405F19004B4C73D91
   |texte=   Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024